Evaxion biotech to host q2 2022 corporate update conference call & webcast on august 10

Copenhagen, denmark, july 29, 2022 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage biotechnology company specializing in the development of ai-driven immunotherapies, announced today that it will present its second-quarter 2022 financial results on august 10 at 8.30 a.m. edt.
EVAX Ratings Summary
EVAX Quant Ranking